甲状腺自身免疫与早发性卵巢功能不全风险升高相关:一项全国健康保险研究数据库研究
该研究基于台湾全民健康保险研究数据库的纵向回顾性队列,分析21 325名20–40岁受试者,比较桥本氏病、格雷夫斯病与年龄匹配对照组的卵巢功能不全结局。结果显示甲状腺自身免疫显著增加早发性卵巢功能不全风险,桥本氏病患者闭经风险高89%、卵巢因素不孕风险高2.40倍,格雷夫斯病患者闭经风险高68%。
要点
- 桥本氏病患者闭经风险较非桥本氏病对照组高89%(95%CI 1.36–2.61)。
- 桥本氏病患者卵巢因素不孕风险为非桥本氏病受试者的2.40倍(HR=2.40,95%CI 1.02–5.68)。
- 格雷夫斯病患者调整后闭经风险较非格雷夫斯病对照组高68%(95%CI 1.43–1.98)。
核心结论
- 甲状腺自身免疫显著增加女性早发性卵巢功能不全的风险。
研究设计与样本
- 基于台湾全民健康保险研究数据库的纵向人群回顾性队列研究,纳入2000年1月1日至2012年12月31日期间20–40岁受试者共21 325名。
- 设桥本氏病队列和格雷夫斯病队列,对照组为无自身免疫性甲状腺疾病的数据库患者,按年龄1:4匹配。
主要发现
- 桥本氏病患者闭经风险较非桥本氏病队列高89%(95%CI 1.36–2.61)。
- 桥本氏病患者卵巢因素不孕风险为非桥本氏病受试者的2.40倍(HR=2.40,95%CI 1.02–5.68)。
- 格雷夫斯病患者调整后闭经风险较非格雷夫斯病队列高68%(95%CI 1.43–1.98)。
- Kaplan-Meier分析显示甲状腺自身免疫组闭经和绝经综合征的累积发生率显著高于对照组。
临床怎么用
- 对诊断为自身免疫性甲状腺疾病的不孕患者,可考虑将不孕治疗方向调整为更高效的方法。
- 若诊断甲状腺自身免疫疾病时卵巢储备正常,建议密切随访卵巢储备。
局限性
- 本研究为回顾性研究,使用ICD-9疾病编码分析确定两种疾病间的统计学关联。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Is thyroid autoimmunity associated with a higher risk of low ovarian reserve and POI? SUMMARY ANSWER: Thyroid autoimmunity significantly increases the risk of POI in women. WHAT IS KNOWN ALREADY: POI is closely related with autoimmune disease, and according to some studies, thyroid autoimmunity (TAI) may account for diminished ovarian reserve. However, no large-scale cohort study has demonstrated the association between TAI and POI. STUDY DESIGN, SIZE, DURATION: A longitudinal population-based retrospective cohort study on the National Health Insurance Research Database (NHIRD) was designed. Since 1 March 1995, the National Health Insurance (NHI) programme in Taiwan has included 99.9% of the 23 million population of Taiwan. Patients between 1 January 2000 and 31 December 2012 were eligible for recruitment, and 21 325 subjects were analysed in our study. PARTICIPANTS/MATERIALS, SETTING, METHODS: Two cohorts, Hashimoto's and Grave's disease, were composed of patients with autoimmune thyroid disease between 20 and 40 years of age. The comparison cohorts consisted of patients in the NHIRD without autoimmune thyroid disease matched by age at a ratio of 1:4 in subject numbers. MAIN RESULTS AND THE ROLE OF CHANCE: The Hashimoto's disease (HD) cohort, Grave's disease (GD) cohort and two comparison cohorts were followed up until a diagnosis of amenorrhoea, menopausal syndrome, other ovarian failure or infertility due to ovarian failure had been made. Compared statistically with the non-HD cohort, patients with HD exhibited an 89% higher risk of amenorrhoea (95% CI =1.36-2.61). The HD patients exhibited a 2.40-fold higher risk of infertility due to ovarian failure than the non-HD subjects (hazard ratio (HR)=2.40, 95% confidence interval (CI)=1.02-5.68). In comparison with the non-GD cohort, patients with GD exhibited a 68% higher risk of amenorrhoea (95% CI = 1.43-1.98) after adjustment. According to the Kaplan-Meier analysis, the cumulative incidence of amenorrhoea and menopausal syndrome was significantly higher in the TAI groups than in the control groups. LIMITATIONS, REASONS FOR CAUTION: This is a retrospective study using ICD-9 disease code analysis to determine the statistical association between two diseases. WIDER IMPLICATIONS OF THE FINDINGS: Given that autoimmune thyroid disease is highly associated with early diminished ovarian reserve or even premature ovarian failure or POI, the options for infertility treatment may be re-directed to more efficient methods in infertile patients diagnosed with the disease. If the ovarian reserve is normal at the time of diagnosis of thyroid autoimmune disease, close follow-up of ovarian reserve may be highly recommended. STUDY FUNDING/COMPETING INTEREST(S): This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial Center, Grant Number: MOHW109-TDU-B-212-114004. The authors have no conflicts of interest to declare. TRIAL REGISTRATION NUMBER: N/A.
引用
- Hsieh YT, Ho JYP. Thyroid autoimmunity is associated with higher risk of premature ovarian insufficiency-a nationwide Health Insurance Research Database study. Hum Reprod. 2021. PMID: 33569594. doi:10.1093/humrep/deab025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。